Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP
Background Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective To evaluate the incidence and risk factors of PEP in WGC. Design Single-center retrospective study. Setting Academic center. Patients A...
Gespeichert in:
| Veröffentlicht in: | Gastrointestinal endoscopy 2015, Vol.81 (1), p.119-126 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 126 |
|---|---|
| container_issue | 1 |
| container_start_page | 119 |
| container_title | Gastrointestinal endoscopy |
| container_volume | 81 |
| creator | Nakai, Yousuke, MD, PhD Isayama, Hiroyuki, MD, PhD Sasahira, Naoki, MD, PhD Kogure, Hirofumi, MD, PhD Sasaki, Takashi, MD, PhD Yamamoto, Natsuyo, MD, PhD Saito, Kei, MD Umefune, Gyotane, MD Akiyama, Dai, MD Kawahata, Shuhei, MD Matsukawa, Miho, MD Saito, Tomotaka, MD Hamada, Tsuyoshi, MD, PhD Takahara, Naminatsu, MD, PhD Mizuno, Suguru, MD, PhD Miyabayashi, Koji, MD, PhD Mohri, Dai, MD, PhD Hirano, Kenji, MD, PhD Tada, Minoru, MD, PhD Koike, Kazuhiko, MD, PhD |
| description | Background Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective To evaluate the incidence and risk factors of PEP in WGC. Design Single-center retrospective study. Setting Academic center. Patients A total of 800 consecutive patients with a native papilla. Interventions Biliary therapeutic ERCP by using WGC. Main Outcome Measurements The rate of PEP and its risk factors. Results Biliary cannulation was successful by using WGC alone in 70.5%, and the final cannulation rate was 96.1%. Unintentional guidewire insertion and contrast material injection into the pancreatic duct (PD) during cannulation occurred in 55.3% and 21.8%, respectively. The incidence of PEP was 9.5% (mild 5.6%, moderate 2.9%, severe 1.0%). Multivariate analysis revealed a common bile duct (CBD) diameter of |
| doi_str_mv | 10.1016/j.gie.2014.06.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1639497525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016510714018380</els_id><sourcerecordid>1639497525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-d5502d456d2fe936a290ff1661c892a8ee7b5ce1850671e33ebf538178cc78a3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS1ERYfCA7BBWbJJuHbinwgJCY3Kj1SJqu3e8jg3xdOMHWynqG9fhyksWLDywt859v0uIW8oNBSoeL9vbh02DGjXgGgA-DOyodDLWkjZPycbKFDNKchT8jKlPQAo1tIX5JTxrmOgYEP0lUt31WhsDjFVY4jVHFKuz6-2l9VsvI1osssuVc5Xv1zE-nZxAw6VNd4vU7kL_ncq_8BoZlyys9XOTc7Eh2oteUVORjMlfP10npGbz-c326_1xfcv37afLmrbyS7XA-fAho6LgY3Yt8KwHsaRCkGt6plRiHLHLVLFQUiKbYu7kbeKSmWtVKY9I--OtXMMPxdMWR9csjhNxmNYkqai7btecsYLSo-ojSGliKOeozuU_2oKetWq97po1atWDUIXrSXz9ql-2R1w-Jv447EAH44AlhnvHUadrENvcSjObNZDcP-t__hP2k7OO2umO3zAtA9L9EWepjoxDfp63eu6VtoBVW15_hHW7pyO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639497525</pqid></control><display><type>article</type><title>Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nakai, Yousuke, MD, PhD ; Isayama, Hiroyuki, MD, PhD ; Sasahira, Naoki, MD, PhD ; Kogure, Hirofumi, MD, PhD ; Sasaki, Takashi, MD, PhD ; Yamamoto, Natsuyo, MD, PhD ; Saito, Kei, MD ; Umefune, Gyotane, MD ; Akiyama, Dai, MD ; Kawahata, Shuhei, MD ; Matsukawa, Miho, MD ; Saito, Tomotaka, MD ; Hamada, Tsuyoshi, MD, PhD ; Takahara, Naminatsu, MD, PhD ; Mizuno, Suguru, MD, PhD ; Miyabayashi, Koji, MD, PhD ; Mohri, Dai, MD, PhD ; Hirano, Kenji, MD, PhD ; Tada, Minoru, MD, PhD ; Koike, Kazuhiko, MD, PhD</creator><creatorcontrib>Nakai, Yousuke, MD, PhD ; Isayama, Hiroyuki, MD, PhD ; Sasahira, Naoki, MD, PhD ; Kogure, Hirofumi, MD, PhD ; Sasaki, Takashi, MD, PhD ; Yamamoto, Natsuyo, MD, PhD ; Saito, Kei, MD ; Umefune, Gyotane, MD ; Akiyama, Dai, MD ; Kawahata, Shuhei, MD ; Matsukawa, Miho, MD ; Saito, Tomotaka, MD ; Hamada, Tsuyoshi, MD, PhD ; Takahara, Naminatsu, MD, PhD ; Mizuno, Suguru, MD, PhD ; Miyabayashi, Koji, MD, PhD ; Mohri, Dai, MD, PhD ; Hirano, Kenji, MD, PhD ; Tada, Minoru, MD, PhD ; Koike, Kazuhiko, MD, PhD</creatorcontrib><description>Background Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective To evaluate the incidence and risk factors of PEP in WGC. Design Single-center retrospective study. Setting Academic center. Patients A total of 800 consecutive patients with a native papilla. Interventions Biliary therapeutic ERCP by using WGC. Main Outcome Measurements The rate of PEP and its risk factors. Results Biliary cannulation was successful by using WGC alone in 70.5%, and the final cannulation rate was 96.1%. Unintentional guidewire insertion and contrast material injection into the pancreatic duct (PD) during cannulation occurred in 55.3% and 21.8%, respectively. The incidence of PEP was 9.5% (mild 5.6%, moderate 2.9%, severe 1.0%). Multivariate analysis revealed a common bile duct (CBD) diameter of <9 mm (odds ratio [OR] 2.03; P = .006) and unintentional guidewire insertion into the PD (OR 2.25; P = .014) as risk factors for PEP. PD opacification was not a risk factor for PEP (OR 1.15; P = .642), but the incremental increase of the PEP rate was seen in patients with CBDs <9 mm: 4.6% without any PD manipulation, 8.3% with contrast material alone, 16.9% with guidewire alone, and 22.1% with both contrast material and guidewire. Limitations Retrospective design in a single center. Conclusion Unintentional PD manipulation was not uncommon in WGC. Guidewire insertion into the PD and a small CBD were risk factors for PEP in biliary therapeutic ERCP with the use of WGC.</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/j.gie.2014.06.005</identifier><identifier>PMID: 25442080</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Ampulla of Vater - surgery ; Bile Duct Diseases - surgery ; Cholangiopancreatography, Endoscopic Retrograde - adverse effects ; Choledocholithiasis - surgery ; Cholestasis - surgery ; Common Bile Duct - surgery ; Constriction, Pathologic - surgery ; Female ; Gastroenterology and Hepatology ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Pancreatic Ducts - surgery ; Pancreatic Neoplasms - complications ; Pancreatic Neoplasms - surgery ; Pancreatitis - epidemiology ; Pancreatitis - etiology ; Retrospective Studies ; Risk Factors ; Sphincterotomy, Endoscopic - adverse effects</subject><ispartof>Gastrointestinal endoscopy, 2015, Vol.81 (1), p.119-126</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-d5502d456d2fe936a290ff1661c892a8ee7b5ce1850671e33ebf538178cc78a3</citedby><cites>FETCH-LOGICAL-c474t-d5502d456d2fe936a290ff1661c892a8ee7b5ce1850671e33ebf538178cc78a3</cites><orcidid>0000-0002-1265-3100 ; 0000-0001-9748-3800 ; 0000-0003-2290-9373 ; 0000-0002-9133-5599</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0016510714018380$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25442080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakai, Yousuke, MD, PhD</creatorcontrib><creatorcontrib>Isayama, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Sasahira, Naoki, MD, PhD</creatorcontrib><creatorcontrib>Kogure, Hirofumi, MD, PhD</creatorcontrib><creatorcontrib>Sasaki, Takashi, MD, PhD</creatorcontrib><creatorcontrib>Yamamoto, Natsuyo, MD, PhD</creatorcontrib><creatorcontrib>Saito, Kei, MD</creatorcontrib><creatorcontrib>Umefune, Gyotane, MD</creatorcontrib><creatorcontrib>Akiyama, Dai, MD</creatorcontrib><creatorcontrib>Kawahata, Shuhei, MD</creatorcontrib><creatorcontrib>Matsukawa, Miho, MD</creatorcontrib><creatorcontrib>Saito, Tomotaka, MD</creatorcontrib><creatorcontrib>Hamada, Tsuyoshi, MD, PhD</creatorcontrib><creatorcontrib>Takahara, Naminatsu, MD, PhD</creatorcontrib><creatorcontrib>Mizuno, Suguru, MD, PhD</creatorcontrib><creatorcontrib>Miyabayashi, Koji, MD, PhD</creatorcontrib><creatorcontrib>Mohri, Dai, MD, PhD</creatorcontrib><creatorcontrib>Hirano, Kenji, MD, PhD</creatorcontrib><creatorcontrib>Tada, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Koike, Kazuhiko, MD, PhD</creatorcontrib><title>Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Background Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective To evaluate the incidence and risk factors of PEP in WGC. Design Single-center retrospective study. Setting Academic center. Patients A total of 800 consecutive patients with a native papilla. Interventions Biliary therapeutic ERCP by using WGC. Main Outcome Measurements The rate of PEP and its risk factors. Results Biliary cannulation was successful by using WGC alone in 70.5%, and the final cannulation rate was 96.1%. Unintentional guidewire insertion and contrast material injection into the pancreatic duct (PD) during cannulation occurred in 55.3% and 21.8%, respectively. The incidence of PEP was 9.5% (mild 5.6%, moderate 2.9%, severe 1.0%). Multivariate analysis revealed a common bile duct (CBD) diameter of <9 mm (odds ratio [OR] 2.03; P = .006) and unintentional guidewire insertion into the PD (OR 2.25; P = .014) as risk factors for PEP. PD opacification was not a risk factor for PEP (OR 1.15; P = .642), but the incremental increase of the PEP rate was seen in patients with CBDs <9 mm: 4.6% without any PD manipulation, 8.3% with contrast material alone, 16.9% with guidewire alone, and 22.1% with both contrast material and guidewire. Limitations Retrospective design in a single center. Conclusion Unintentional PD manipulation was not uncommon in WGC. Guidewire insertion into the PD and a small CBD were risk factors for PEP in biliary therapeutic ERCP with the use of WGC.</description><subject>Aged</subject><subject>Ampulla of Vater - surgery</subject><subject>Bile Duct Diseases - surgery</subject><subject>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</subject><subject>Choledocholithiasis - surgery</subject><subject>Cholestasis - surgery</subject><subject>Common Bile Duct - surgery</subject><subject>Constriction, Pathologic - surgery</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Pancreatic Ducts - surgery</subject><subject>Pancreatic Neoplasms - complications</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Pancreatitis - epidemiology</subject><subject>Pancreatitis - etiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sphincterotomy, Endoscopic - adverse effects</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS1ERYfCA7BBWbJJuHbinwgJCY3Kj1SJqu3e8jg3xdOMHWynqG9fhyksWLDywt859v0uIW8oNBSoeL9vbh02DGjXgGgA-DOyodDLWkjZPycbKFDNKchT8jKlPQAo1tIX5JTxrmOgYEP0lUt31WhsDjFVY4jVHFKuz6-2l9VsvI1osssuVc5Xv1zE-nZxAw6VNd4vU7kL_ncq_8BoZlyys9XOTc7Eh2oteUVORjMlfP10npGbz-c326_1xfcv37afLmrbyS7XA-fAho6LgY3Yt8KwHsaRCkGt6plRiHLHLVLFQUiKbYu7kbeKSmWtVKY9I--OtXMMPxdMWR9csjhNxmNYkqai7btecsYLSo-ojSGliKOeozuU_2oKetWq97po1atWDUIXrSXz9ql-2R1w-Jv447EAH44AlhnvHUadrENvcSjObNZDcP-t__hP2k7OO2umO3zAtA9L9EWepjoxDfp63eu6VtoBVW15_hHW7pyO</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Nakai, Yousuke, MD, PhD</creator><creator>Isayama, Hiroyuki, MD, PhD</creator><creator>Sasahira, Naoki, MD, PhD</creator><creator>Kogure, Hirofumi, MD, PhD</creator><creator>Sasaki, Takashi, MD, PhD</creator><creator>Yamamoto, Natsuyo, MD, PhD</creator><creator>Saito, Kei, MD</creator><creator>Umefune, Gyotane, MD</creator><creator>Akiyama, Dai, MD</creator><creator>Kawahata, Shuhei, MD</creator><creator>Matsukawa, Miho, MD</creator><creator>Saito, Tomotaka, MD</creator><creator>Hamada, Tsuyoshi, MD, PhD</creator><creator>Takahara, Naminatsu, MD, PhD</creator><creator>Mizuno, Suguru, MD, PhD</creator><creator>Miyabayashi, Koji, MD, PhD</creator><creator>Mohri, Dai, MD, PhD</creator><creator>Hirano, Kenji, MD, PhD</creator><creator>Tada, Minoru, MD, PhD</creator><creator>Koike, Kazuhiko, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1265-3100</orcidid><orcidid>https://orcid.org/0000-0001-9748-3800</orcidid><orcidid>https://orcid.org/0000-0003-2290-9373</orcidid><orcidid>https://orcid.org/0000-0002-9133-5599</orcidid></search><sort><creationdate>2015</creationdate><title>Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP</title><author>Nakai, Yousuke, MD, PhD ; Isayama, Hiroyuki, MD, PhD ; Sasahira, Naoki, MD, PhD ; Kogure, Hirofumi, MD, PhD ; Sasaki, Takashi, MD, PhD ; Yamamoto, Natsuyo, MD, PhD ; Saito, Kei, MD ; Umefune, Gyotane, MD ; Akiyama, Dai, MD ; Kawahata, Shuhei, MD ; Matsukawa, Miho, MD ; Saito, Tomotaka, MD ; Hamada, Tsuyoshi, MD, PhD ; Takahara, Naminatsu, MD, PhD ; Mizuno, Suguru, MD, PhD ; Miyabayashi, Koji, MD, PhD ; Mohri, Dai, MD, PhD ; Hirano, Kenji, MD, PhD ; Tada, Minoru, MD, PhD ; Koike, Kazuhiko, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-d5502d456d2fe936a290ff1661c892a8ee7b5ce1850671e33ebf538178cc78a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Ampulla of Vater - surgery</topic><topic>Bile Duct Diseases - surgery</topic><topic>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</topic><topic>Choledocholithiasis - surgery</topic><topic>Cholestasis - surgery</topic><topic>Common Bile Duct - surgery</topic><topic>Constriction, Pathologic - surgery</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Pancreatic Ducts - surgery</topic><topic>Pancreatic Neoplasms - complications</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Pancreatitis - epidemiology</topic><topic>Pancreatitis - etiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sphincterotomy, Endoscopic - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakai, Yousuke, MD, PhD</creatorcontrib><creatorcontrib>Isayama, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Sasahira, Naoki, MD, PhD</creatorcontrib><creatorcontrib>Kogure, Hirofumi, MD, PhD</creatorcontrib><creatorcontrib>Sasaki, Takashi, MD, PhD</creatorcontrib><creatorcontrib>Yamamoto, Natsuyo, MD, PhD</creatorcontrib><creatorcontrib>Saito, Kei, MD</creatorcontrib><creatorcontrib>Umefune, Gyotane, MD</creatorcontrib><creatorcontrib>Akiyama, Dai, MD</creatorcontrib><creatorcontrib>Kawahata, Shuhei, MD</creatorcontrib><creatorcontrib>Matsukawa, Miho, MD</creatorcontrib><creatorcontrib>Saito, Tomotaka, MD</creatorcontrib><creatorcontrib>Hamada, Tsuyoshi, MD, PhD</creatorcontrib><creatorcontrib>Takahara, Naminatsu, MD, PhD</creatorcontrib><creatorcontrib>Mizuno, Suguru, MD, PhD</creatorcontrib><creatorcontrib>Miyabayashi, Koji, MD, PhD</creatorcontrib><creatorcontrib>Mohri, Dai, MD, PhD</creatorcontrib><creatorcontrib>Hirano, Kenji, MD, PhD</creatorcontrib><creatorcontrib>Tada, Minoru, MD, PhD</creatorcontrib><creatorcontrib>Koike, Kazuhiko, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakai, Yousuke, MD, PhD</au><au>Isayama, Hiroyuki, MD, PhD</au><au>Sasahira, Naoki, MD, PhD</au><au>Kogure, Hirofumi, MD, PhD</au><au>Sasaki, Takashi, MD, PhD</au><au>Yamamoto, Natsuyo, MD, PhD</au><au>Saito, Kei, MD</au><au>Umefune, Gyotane, MD</au><au>Akiyama, Dai, MD</au><au>Kawahata, Shuhei, MD</au><au>Matsukawa, Miho, MD</au><au>Saito, Tomotaka, MD</au><au>Hamada, Tsuyoshi, MD, PhD</au><au>Takahara, Naminatsu, MD, PhD</au><au>Mizuno, Suguru, MD, PhD</au><au>Miyabayashi, Koji, MD, PhD</au><au>Mohri, Dai, MD, PhD</au><au>Hirano, Kenji, MD, PhD</au><au>Tada, Minoru, MD, PhD</au><au>Koike, Kazuhiko, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2015</date><risdate>2015</risdate><volume>81</volume><issue>1</issue><spage>119</spage><epage>126</epage><pages>119-126</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><abstract>Background Wire-guided cannulation (WGC) was reported to decrease post-ERCP pancreatitis (PEP), but risk factors for PEP in WGC are not fully elucidated. Objective To evaluate the incidence and risk factors of PEP in WGC. Design Single-center retrospective study. Setting Academic center. Patients A total of 800 consecutive patients with a native papilla. Interventions Biliary therapeutic ERCP by using WGC. Main Outcome Measurements The rate of PEP and its risk factors. Results Biliary cannulation was successful by using WGC alone in 70.5%, and the final cannulation rate was 96.1%. Unintentional guidewire insertion and contrast material injection into the pancreatic duct (PD) during cannulation occurred in 55.3% and 21.8%, respectively. The incidence of PEP was 9.5% (mild 5.6%, moderate 2.9%, severe 1.0%). Multivariate analysis revealed a common bile duct (CBD) diameter of <9 mm (odds ratio [OR] 2.03; P = .006) and unintentional guidewire insertion into the PD (OR 2.25; P = .014) as risk factors for PEP. PD opacification was not a risk factor for PEP (OR 1.15; P = .642), but the incremental increase of the PEP rate was seen in patients with CBDs <9 mm: 4.6% without any PD manipulation, 8.3% with contrast material alone, 16.9% with guidewire alone, and 22.1% with both contrast material and guidewire. Limitations Retrospective design in a single center. Conclusion Unintentional PD manipulation was not uncommon in WGC. Guidewire insertion into the PD and a small CBD were risk factors for PEP in biliary therapeutic ERCP with the use of WGC.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25442080</pmid><doi>10.1016/j.gie.2014.06.005</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1265-3100</orcidid><orcidid>https://orcid.org/0000-0001-9748-3800</orcidid><orcidid>https://orcid.org/0000-0003-2290-9373</orcidid><orcidid>https://orcid.org/0000-0002-9133-5599</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0016-5107 |
| ispartof | Gastrointestinal endoscopy, 2015, Vol.81 (1), p.119-126 |
| issn | 0016-5107 1097-6779 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1639497525 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Ampulla of Vater - surgery Bile Duct Diseases - surgery Cholangiopancreatography, Endoscopic Retrograde - adverse effects Choledocholithiasis - surgery Cholestasis - surgery Common Bile Duct - surgery Constriction, Pathologic - surgery Female Gastroenterology and Hepatology Humans Male Middle Aged Multivariate Analysis Pancreatic Ducts - surgery Pancreatic Neoplasms - complications Pancreatic Neoplasms - surgery Pancreatitis - epidemiology Pancreatitis - etiology Retrospective Studies Risk Factors Sphincterotomy, Endoscopic - adverse effects |
| title | Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A17%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20post-ERCP%20pancreatitis%20in%20wire-guided%20cannulation%20for%20therapeutic%20biliary%20ERCP&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Nakai,%20Yousuke,%20MD,%20PhD&rft.date=2015&rft.volume=81&rft.issue=1&rft.spage=119&rft.epage=126&rft.pages=119-126&rft.issn=0016-5107&rft.eissn=1097-6779&rft_id=info:doi/10.1016/j.gie.2014.06.005&rft_dat=%3Cproquest_cross%3E1639497525%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1639497525&rft_id=info:pmid/25442080&rft_els_id=S0016510714018380&rfr_iscdi=true |